ASPIRE HIGHER Trademark

Trademark Overview

On Tuesday, February 2, 2010, a trademark application was filed for ASPIRE HIGHER with the United States Patent and Trademark Office. The USPTO has given the ASPIRE HIGHER trademark a serial number of 77926007. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2013. This trademark is owned by Novartis AG. The ASPIRE HIGHER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals
aspire higher

General Information

Serial Number77926007
Word MarkASPIRE HIGHER
Filing DateTuesday, February 2, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2010

Trademark Statements

Goods and Servicesproviding medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 11, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, October 7, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 7, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, March 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2013EXTENSION 5 GRANTED
Tuesday, March 5, 2013EXTENSION 5 FILED
Tuesday, March 5, 2013TEAS EXTENSION RECEIVED
Friday, September 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 6, 2012EXTENSION 4 GRANTED
Tuesday, September 4, 2012EXTENSION 4 FILED
Wednesday, September 5, 2012TEAS EXTENSION RECEIVED
Tuesday, March 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 5, 2012EXTENSION 3 GRANTED
Wednesday, February 29, 2012EXTENSION 3 FILED
Wednesday, February 29, 2012TEAS EXTENSION RECEIVED
Thursday, September 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2011EXTENSION 2 GRANTED
Tuesday, September 6, 2011EXTENSION 2 FILED
Wednesday, September 7, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2011TEAS EXTENSION RECEIVED
Tuesday, March 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2011EXTENSION 1 GRANTED
Friday, March 4, 2011EXTENSION 1 FILED
Friday, March 4, 2011TEAS EXTENSION RECEIVED
Tuesday, September 7, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2010PUBLISHED FOR OPPOSITION
Monday, June 7, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 7, 2010ASSIGNED TO LIE
Saturday, May 22, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 3, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 3, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 27, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 27, 2010NON-FINAL ACTION E-MAILED
Saturday, March 27, 2010NON-FINAL ACTION WRITTEN
Friday, March 19, 2010ASSIGNED TO EXAMINER
Thursday, February 11, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 5, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

higher aspire research medical trials clinical professionals pharmaceuticals information scientific providing field